Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ali Baaj

Neurological Surgery New York, NY Medical Doctor

NPI 1417148800 CMS profile 109181

525 E 68Th St, Box 99, New York, NY 10065

Open in the dashboard

General payments

$239,996

296 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ali Baaj of New York, NY is reported in the CMS Open Payments database as having received $239,996 across 296 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28,500 58
2024 General $8,954 27
2023 General $21,552 29
2022 General $26,192 37
2021 General $37,794 52
2020 General $29,631 20
2019 General $87,373 73

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ali Baaj
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Ali Baaj were reported at $28,500. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Ali Baaj Neurological Surgery median Middle half National median
2019 $87,373 $582 $138–$3,006 $163
2020 $29,631 $294 $76–$2,174 $114
2021 $37,794 $387 $105–$2,432 $132
2022 $26,192 $542 $139–$2,989 $149
2023 $21,552 $534 $145–$2,697 $160
2024 $8,954 $574 $155–$3,046 $164
2025 $28,500 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medical Device Business Services, Inc. $169,671 83 payments
  2. Synthes GmbH $22,002 20 payments
  3. DePuy Synthes Products, Inc. $20,801 29 payments
  4. Ethicon US, LLC $10,310 2 payments
  5. Stryker Corporation $5,273 39 payments
  6. DePuy Synthes Sales Inc. $4,290 55 payments
  7. Medtronic, Inc. $3,957 24 payments
  8. Abbott Laboratories $1,936 15 payments
  9. Alphatec Spine, Inc $479 5 payments
  10. Spineart USA Inc $288 4 payments
  11. Other $990 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $190,186 40 payments
  2. Travel and Lodging $22,011 60 payments
  3. Food and Beverage $14,425 185 payments
  4. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $7,563 4 payments
  5. Honoraria $4,312 5 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $1,500 2 payments
Products named General payments · program years 2019–2025
  1. VIPER Spine $57,405 19 payments
  2. CONCORDE $50,454 15 payments
  3. EXPEDIUM $36,866 15 payments
  4. CONDUIT $5,605 16 payments
  5. VIPER Spine $4,788 12 payments
  6. COUGAR $4,095 1 payment
  7. MAZOR X SYSTEM $2,988 15 payments
  8. Spine & Trauma 3D Navigation $2,068 24 payments
  9. SERRATO $1,700 1 payment
  10. SYMPHONY $1,648 13 payments
  11. Other $12,514 127 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$77,003

Medicare's payments for the services billed

Medicare patients

84

Average age 73

Services billed

257

46 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 70%
Diabetes 36%
Chronic kidney disease 31%
Depression 31%
Cancer 25%
Ischemic heart disease 23%
Osteoporosis 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

296 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record